Efficacy of the melanocortin analogue Nle4-D-Phe7-α-melanocyte- stimulating hormone in the treatment of patients with Hailey-Hailey disease

Clinical and Experimental Dermatology

Volumn 39, Issue 2, 2014, Pages 168-175

  Biolcati, G ^a   Aurizi, C ^a   Barbieri, L ^a   Cialfi, S ^b   Screpanti, I ^b   Talora, C ^b  

^a SAN GALLICANO DERMATOLOGICAL INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AFAMELANOTIDE; TRANSCRIPTION FACTOR NRF2;

ADULT; ANTIOXIDANT ACTIVITY; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HAILEY HAILEY DISEASE; HUMAN; HUMAN CELL; KERATINOCYTE; MALE; OPEN STUDY; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ALPHA-MSH; ANTIOXIDANTS; CELL PROLIFERATION; FEMALE; HUMANS; KERATINOCYTES; MALE; MIDDLE AGED; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; PEMPHIGUS, BENIGN FAMILIAL; PILOT PROJECTS;

EID: 84894046969     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/ced.12203     Document Type: Article

References (21)

1. Kellermayer R,. Hailey-Hailey disease from a clinical perspective. Cell Calcium 2008; 43: 105-6.
2. Hu Z, Bonifas JM, Beech J, et al,. Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease. Nat Genet 2000; 24: 61-5.
3. Cialfi S, Oliviero C, Ceccarelli S, et al,. Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease. Br J Dermatol 2010; 162: 518-26.
4. Manca S, Magrelli A, Cialfi S, et al,. Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation. Exp Dermatol 2011; 20: 932-7.
5. Abdel-Malek ZA,. Melanocortin receptors: their functions and regulation by physiological agonists and antagonists. Cell Mol Life Sci 2001; 58: 434-41.
6. Bohm M, Luger TA,. Alpha-melanocyte-stimulating hormone. From bench to bedside. Hautarzt 2010; 61: 497-504 (in German).
7. Hoogduijn MJ, McGurk S, Smit NP, et al,. Ligand-dependent activation of the melanocortin 5 receptor: cAMP production and ryanodine receptor-dependent elevations of [Ca (2+)] (I). Biochem Biophys Res Commun 2002; 290: 844-50.
8. Bohm M, Luger TA,. Alpha-melanocyte-stimulating hormone. Its current significance for dermatology. Hautarzt 2004; 55: 436-45 (in German).
9. Haycock JW, Rowe SJ, Cartledge S, et al,. Alpha-melanocyte-stimulating hormone reduces impact of proinflammatory cytokine and peroxide-generated oxidative stress on keratinocyte and melanoma cell lines. J Biol Chem 2000; 275: 15629-36.
10. Kokot A, Metze D, Mouchet N, et al,. Alpha-melanocyte-stimulating hormone counteracts the suppressive effect of UVB on Nrf2 and Nrf-dependent gene expression in human skin. Endocrinology 2009; 150: 3197-206.
11. Song X, Mosby N, Yang J, et al,. Alpha-MSH activates immediate defense responses to UV-induced oxidative stress in human melanocytes. Pigment Cell Melanoma Res 2009; 22: 809-18.
12. Henri P, Beaumel S, Guezennec A, et al,. MC1R expression in HaCaT keratinocytes inhibits UVA-induced ROS production via NADPH oxidase- and cAMP-dependent mechanisms. J Cell Physiol 2012; 227: 2578-85.
13. Kadekaro AL, Chen J, Yang J, et al,. Alpha-melanocyte-stimulating hormone suppresses oxidative stress through a p53-mediated signaling pathway in human melanocytes. Mol Cancer Res 2012; 10: 778-86.
14. Kensler TW, Wakabayashi N, Biswal S,. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol 2007; 47: 89-116.
15. Zhang DD,. Mechanistic studies of the Nrf2-Keap1 signaling pathway. Drug Metab Rev 2006; 38: 769-89.
16. Kobayashi M, Yamamoto M,. Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxid Redox Signal 2005; 7: 385-94.
17. Harms J, Lautenschlager S, Minder CE, Minder EI,. An alpha-melanocyte- stimulating hormone analogue in erythropoietic protoporphyria. N Engl J Med 2009; 360: 306-7.
18. Cialfi S, Palermo R, Manca S, et al,. Glucocorticoid sensitivity of T-cell lymphoblastic leukemia/lymphoma is associated with glucocorticoid receptor-mediated inhibition of Notch1 expression. Leukemia 2013; 27: 485-8.
19. Applied Biosystems. User Bulletin. Relative Quantification of Gene Expression. ABI PRISM 7700 Sequence Detection System: User Bulletin 2: Rev B.
20. Talora C, Cialfi S, Oliviero C, et al,. Cross talk among Notch3, pre-TCR, and Tal1 in T-cell development and leukemogenesis. Blood 2006; 107: 3313-20.
21. Bohm M, Ehrchen J, Luger TA,. Beneficial effects of the melanocortin analogue Nle4-D-Phe7-alpha-MSH in acne vulgaris. J Eur Acad Dermatol Venereol 2012; doi: 10.1111/j.1468-3083.2012.04658.x.